Text Size

Cross-Over Evaluation of Two Lubricating Eye Drops

This study has been completed.
Sponsor:
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00493662
First received: June 26, 2007
Last updated: January 11, 2008
Last verified: January 2008
History of Changes
  Purpose

To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.


Condition Intervention Phase
Dry Eye
 Drug: Polyethylene Glycol 400 0.4%
Drug: Propylene Glycol 0.3%
Drug: 0.15% sodium Hyaluronate
Drug: sodium chloride
Drug: sodium phosphate monobasic
 Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Innovative Medical:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  1. Patients 18 yrs or older
  2. Males or females
  3. Any race or ethnic background
  4. Patients with present ocular surface discomfort and a SESoD score of at least 2

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia.
  4. Current use of Restasis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00493662

Locations
United States, Pennsylvania
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States, 18202
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Tom Kislan, OD Hazleton Eye Specialists
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00493662     History of Changes
Other Study ID Numbers: 5310
Study First Received: June 26, 2007
Last Updated: January 11, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hyaluronic Acid
Sodium phosphate
Adjuvants, Immunologic
Immunologic Factors
Physiological Effects of Drugs
 Pharmacologic Actions
Cathartics
Gastrointestinal Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on May 19, 2013